Phenotypic characterisation of autosomal recessive PARK6-linked parkinsonism in three unrelated Italian families

Istituto di Neurologia, Università Cattolica, Roma, Italy.
Movement Disorders (Impact Factor: 5.68). 12/2001; 16(6):999-1006.
Source: PubMed


The clinical features of nine patients (three women and six men) affected by PARK6-linked parkinsonism, belonging to three unrelated Italian families, are reported. The occurrence of affected men and women within one generation suggested an autosomal recessive mode of inheritance in all three families. Mean age at disease onset was 36 +/- 4.6 years; all cases except one presented with asymmetrical signs, consisting of tremor and akinesia of one upper limb or unilateral short step gait. Affected individuals had a mean age of 57 +/- 8.5 years, and average disease duration was 21 +/- 7.8 years. Parkinsonian features included benign course, early onset of drug-induced dyskinesias, and a good and persistent response to levodopa. There were no other associated features (i.e., pyramidal or cerebellar signs, dysautonomia, or diurnal fluctuations unrelated to drug treatment). Cognition was unaffected. The clinical picture was remarkably similar in all patients; no relevant family-related differences were found. PARK6 disease is a new form of early-onset parkinsonism without other atypical clinical features.

Download full-text


Available from: Anna Rita Bentivoglio,
  • Source
    • "We used the PINK1 − / − mice model of PD to determine whether juvenile (P14–P21) motor cortex networks are hypersynchronized and typify the effect of parkinsonian treatments on this signature. The PINK1 − / − mice is a model of the autosomal recessive PARK6-linked Parkinsonism, an early-onset variant of familial PD caused by loss-of-function mutations in the mitochondrial protein PINK1 (Bentivoglio et al., 2001). PINK1 − / − mice show electrophysiological signs of dopaminergic dysfunction already at the age of 3–6 months and a reduction of locomotor activity 10 months later (Kitada et al., 2007; Dehorter et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: In Parkinson's disease (PD), cortical networks show enhanced synchronized activity but whether this precedes motor signs is unknown. We investigated this question in PINK1(-)/(-) mice, a genetic rodent model of the PARK6 variant of familial PD which shows impaired spontaneous locomotion at 16 months. We used two-photon calcium imaging and whole-cell patch clamp in slices from juvenile (P14-P21) wild-type or PINK1(-)/(-) mice. We designed a horizontal tilted cortico-subthalamic slice where the only connection between cortex and subthalamic nucleus (STN) is the hyperdirect cortico-subthalamic pathway. We report excessive correlation and synchronization in PINK1(-)/(-) M1 cortical networks 15 months before motor impairment. The percentage of correlated pairs of neurons and their strength of correlation were higher in the PINK1(-)/(-) M1 than in the wild type network and the synchronized network events involved a higher percentage of neurons. Both features were independent of thalamo-cortical pathways, insensitive to chronic levodopa treatment of pups, but totally reversed by antidromic invasion of M1 pyramidal neurons by axonal spikes evoked by high frequency stimulation (HFS) of the STN. Our study describes an early excess of synchronization in the PINK1(-)/(-) cortex and suggests a potential role of antidromic activation of cortical interneurons in network desynchronization. Such backward effect on interneurons activity may be of importance for HFS-induced network desynchronization.
    Frontiers in Systems Neuroscience 05/2014; 8:95. DOI:10.3389/fnsys.2014.00095
  • Source
    • "A clear genetic link between mitochondria and PD was defined by our identification of loss-of-function mutations in the mitochondrial protein PINK1 as the cause of autosomal recessive early-onset PARK6-linked Parkinsonism, a variant of PD with particularly early onset and mild progression that affects the autonomic and cognitive nervous system less than sporadic PD [1], [2]. PINK1 is a ubiquitously expressed 581 amino-acid protein with a serine-threonine kinase domain and a mitochondrial signal peptide [3]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Parkinson's disease (PD) is an adult-onset movement disorder of largely unknown etiology. We have previously shown that loss-of-function mutations of the mitochondrial protein kinase PINK1 (PTEN induced putative kinase 1) cause the recessive PARK6 variant of PD. Now we generated a PINK1 deficient mouse and observed several novel phenotypes: A progressive reduction of weight and of locomotor activity selectively for spontaneous movements occurred at old age. As in PD, abnormal dopamine levels in the aged nigrostriatal projection accompanied the reduced movements. Possibly in line with the PARK6 syndrome but in contrast to sporadic PD, a reduced lifespan, dysfunction of brainstem and sympathetic nerves, visible aggregates of alpha-synuclein within Lewy bodies or nigrostriatal neurodegeneration were not present in aged PINK1-deficient mice. However, we demonstrate PINK1 mutant mice to exhibit a progressive reduction in mitochondrial preprotein import correlating with defects of core mitochondrial functions like ATP-generation and respiration. In contrast to the strong effect of PINK1 on mitochondrial dynamics in Drosophila melanogaster and in spite of reduced expression of fission factor Mtp18, we show reduced fission and increased aggregation of mitochondria only under stress in PINK1-deficient mouse neurons. Thus, aging Pink1(-/-) mice show increasing mitochondrial dysfunction resulting in impaired neural activity similar to PD, in absence of overt neuronal death.
    PLoS ONE 02/2009; 4(6):e5777. DOI:10.1371/journal.pone.0005777 · 3.23 Impact Factor
  • Source
    • "Among the 40 or more PINK1 mutations identified in symptomatic individuals, 15 segregate with disease in pedigrees of early onset Parkinsonism. Even though some of the clinical hallmarks of sporadic PD are observed in PD sufferers with PINK1 gene mutations, the underlying mechanism of pathogenesis appears to be a distinct form of familial neurodegeneration (Bentivoglio et al. 2001; Valente et al. 2001, 2004a,b). Atypical clinical features have been observed in PINK1 Parkinsonism, including psychiatric disturbances, dystonia at onset, and sleep benefit (Hatano et al. 2004; Valente et al. 2004a; Tan and Dawson 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mutations in PTEN-induced kinase 1 (PINK1) gene cause PARK6 familial Parkinsonism. To decipher the role of PINK1 in pathogenesis of Parkinson's disease (PD), researchers need to identify protein substrates of PINK1 kinase activity that govern neuronal survival, and establish whether aberrant regulation and inactivation of PINK1 contribute to both familial Parkinsonism and idiopathic PD. These studies should take into account the several unique structural and functional features of PINK1. First PINK1 is a rare example of a protein kinase with a predicted mitochondrial-targeting sequence and a possible resident mitochondrial function. Second, bioinformatic analysis reveals unique insert regions within the kinase domain that are potentially involved in regulation of kinase activity, substrate selectivity and stability of PINK1. Third, the C-terminal region contains functional motifs governing kinase activity and substrate selectivity. Fourth, accumulating evidence suggests that PINK1 interacts with other signaling proteins implicated in PD pathogenesis and mitochondrial dysfunction. The most prominent examples are the E3 ubiquitin ligase Parkin, the mitochondrial protease high temperature requirement serine protease 2 and the mitochondrial chaperone tumor necrosis factor receptor-associated protein 1. How PINK1 may regulate these proteins to maintain neuronal survival is unclear. This review describes the unique structural features of PINK1 and their possible roles in governing mitochondrial import, processing, kinase activity, substrate selectivity and stability of PINK1. Based upon the findings of previous studies of PINK1 function in cell lines and animal models, we propose a model on the neuroprotective mechanism of PINK1. This model may serve as a conceptual framework for future investigation into the molecular basis of PD pathogenesis.
    Journal of Neurochemistry 05/2008; 105(1):18-33. DOI:10.1111/j.1471-4159.2008.05249.x · 4.28 Impact Factor
Show more